Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials

BACKGROUND: We sought to develop a prognostic scoring system to aid in patient selection for immune checkpoint inhibitor (ICI) phase 1 clinical trials. METHODS: Clinical data from patients treated in phase 1 ICI clinical trials at MD Anderson (MDA) Center were analysed. Seventeen clinical factors we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Br J Cancer
Hauptverfasser: Sen, Shiraj, Hess, Kenneth, Hong, David S, Naing, Aung, Piha-Paul, Sarina, Janku, Filip, Fu, Siqing, Subbiah, Ishwaria M, Liu, Holly, Khanji, Rahil, Huang, Le, Moorthy, Shhyam, Karp, Daniel D, Tsimberidou, Apostolia, Meric-Bernstam, Funda, Subbiah, Vivek
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2018
Schlagworte:
Clinical Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5886120/
https://ncbi.nlm.nih.gov/pubmed/29462132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.480
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge